Physician profile
Christopher Ballantyne
NPI 1700317906
$36,823.23
in general payments reported to CMS, 2019-2025
10 companies · $958 in 2025
The $958 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.57 · 2023: $150 · 2024: $36K · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $35K · Food and Beverage: $1,409 · Travel and Lodging: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $35,000.00 |
| Food and Beverage | $1,408.59 |
| Travel and Lodging | $333.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $35,393.78 | 2024 | Ams 700, Lithoclast, Lithovue |
| Calyxo, INC. | $475.19 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $378.46 | 2023-2025 | Altaviva, Interstim |
| Procept Biorobotics Corporation | $149.45 | 2025 | |
| Progenics Pharmaceuticals, INC. | $124.99 | 2024 | |
| Karl Storz Endoscopy-America | $104.78 | 2023 | Flex-X |
| Endo Pharmaceuticals INC. | $81.57 | 2019 | |
| Axonics, INC. | $60.75 | 2024 | Axonics |
| Cook Medical LLC | $28.34 | 2024 | Ncircle |
| Alnylam Pharmaceuticals INC. | $25.92 | 2024 | Oxlumo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ballantyne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.